Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients

about

Bone health in HIV and hepatitis B or C infections Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture.

P2860

Q30238946-C2F95E72-A317-4C1F-A91E-0A2F57525C5E Q38738823-F3C79729-D317-437E-9C51-314FFCB7AABC

P2860

Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients

Item

http://www.wikidata.org/entity/Q36756136

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Effects of Pegylated Interfero ...... is C Virus-Coinfected Patients

@ast

Effects of Pegylated Interfero ...... is C Virus-Coinfected Patients

@en

type

Item

label

Effects of Pegylated Interfero ...... is C Virus-Coinfected Patients

@ast

Effects of Pegylated Interfero ...... is C Virus-Coinfected Patients

@en

prefLabel

Effects of Pegylated Interfero ...... is C Virus-Coinfected Patients

@ast

Effects of Pegylated Interfero ...... is C Virus-Coinfected Patients

@en

P1476

Effects of Pegylated Interfero ...... is C Virus-Coinfected Patients

@en

P2093

Christopher Evans

http://www.w3.org/2001/XMLSchema#string

Debika Bhattacharya

http://www.w3.org/2001/XMLSchema#string

Edgar T Overton

http://www.w3.org/2001/XMLSchema#string

Grace McComsey

http://www.w3.org/2001/XMLSchema#string

Kimberly Hollabaugh

http://www.w3.org/2001/XMLSchema#string

Minhee Kang

http://www.w3.org/2001/XMLSchema#string

Roger Bedimo

http://www.w3.org/2001/XMLSchema#string

Todd T Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.

Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection

Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C.

Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.

Interplay between interferon and other cytokine systems in bone metabolism.

Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C

Inflammation-induced bone loss: can it be prevented?

Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals.

Ribavirin enhances osteoclast formation through osteoblasts via up-regulation of TRANCE/RANKL.

Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin.

P304

325-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/AID.2015.0204

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pablo Tebas

Babafemi Taiwo

P577

2015-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26499270

http://www.w3.org/2001/XMLSchema#string

P932

4817562

http://www.w3.org/2001/XMLSchema#string

Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients

about

P2860

P2860

Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932